(Medical Xpress)—At the request of two drug companies, the Food and Drug Administration (FDA) has announced that it will withdraw approvals for three of four arsenic-based drugs currently approved for use in food animal production. A fourth arsenic-based drug used to make turkeys and chickens grow faster, among other purposes, will remain on the market.
FDA's move follows a study led by the Johns Hopkins Center for a Livable Future (CLF) and published in May 2013 found clear evidence that using these drugs in chicken production increased levels of inorganic arsenic, a known carcinogen, in chicken breast meat.
Earlier this year, the Center for Food Safety (CFS) and the Institute for Agriculture and Trade Policy (IATP) sued the FDA after the agency did not respond to a 2009 petition asking it to withdraw the approvals of all four drugs. The lawsuit forced FDA to respond by today.
"Our research found clear evidence that using arsenic-based drugs in poultry production increased people's exposure to a potent carcinogen. The findings made it clear that continuing to use these drugs would increase the risk of cancer and possibly other diseases too," said Keeve Nachman, PhD, MHS, a member of the faculty of the Bloomberg School of Public Health and lead author of the CLF study. "We are glad that FDA and drug companies have bowed to public health concerns about using arsenic to produce chickens and turkeys, but the agency still has work to do. FDA must withdraw the approvals for nitarsone so that arsenic is no longer used to make food that people eat," added Nachman.
Specifically, the approvals for roxarsone, arsanilic acid, and carbarsone will be withdrawn by FDA at the request of the companies that hold the approvals. Nitarsone, the fourth arsenic-based drug and the only one that has been marketed since 2011, will remain approved and available for use.
The study, "Roxarsone, Inorganic Arsenic, and Other Arsenic Species in Chicken: A U.S.-Based Market Basket Sample," was published in the journal Environmental Health Perspectives in May 2013.
Explore further: Poultry drug increases levels of toxic arsenic in chicken meat
More information: www.jhsph.edu/news/news-releases/2013/nachman_arsenic_chicken.html
Medical Xpress on facebook
Related Stories
Poultry drug increases levels of toxic arsenic in chicken meat
May 13, 2013
(Medical Xpress)—Chickens likely raised with arsenic-based drugs result in chicken meat that has higher levels of inorganic arsenic, a known carcinogen, according to a new study led by researchers at theJohns Hopkins Center ...
Coordinated approach needed to protect from arsenic exposure
May 02, 2013
(HealthDay)—A coordinated approach is necessary for monitoring and regulating the arsenic content of foods, according to a viewpoint piece published online April 29 in JAMA Internal Medicine.
US: Rice is safe, despite small levels of arsenic
Sep 06, 2013
The U.S. Food and Drug Administration says consumers should not worry too much about levels of arsenic in rice—but should vary their diets just in case.
Pfizer will stop selling poultry-pumping drug: US
Jun 08, 2011
The pharmaceutical giant Pfizer will voluntarily suspend US sales of a poultry-pumping additive after studies showed it can leave traces of arsenic in chicken livers, the US government said on Wednesday.
Denmark warns against rice for children
May 15, 2013
Denmark's Veterinary and Food Administration said Wednesday that parents should stop giving their children rice cakes and rice milk, saying the products contained unacceptable levels of inorganic arsenic.
Recommended for you
Doctors still prescribe antibiotics too often, study finds (Update)
17 hours ago
Repeated warnings that antibiotics don't work for most sore throats and bronchitis have failed to stop overuse: U.S. doctors prescribed these drugs for most adults seeking treatment at a rate that remained high over more ...
Following bariatric surgery, use of opioids increases among chronic opioid users
Oct 01, 2013
In a group of patients who took chronic opioids for noncancer pain and who underwent bariatric surgery, there was greater chronic use of opioids after surgery compared with before, findings that suggest the need for proactive ...
Brintellix approved for major depressive disorder
Oct 01, 2013
(HealthDay)—Brintellix (vortioxetine) has been approved by the U.S. Food and Drug Administration to treat adults with major depressive disorder, often referred to as depression.
Over-the counter as effective as Rx at managing post-tonsillectomy pain
Oct 01, 2013
You may be able to eat all of the ice cream you want after having your tonsils removed, but researchers at Henry Ford Hospital in Detroit say you don't necessarily need a prescription to reduce post-operative pain—an over-the-counter ...
Statin medications may prevent dementia and memory loss with longer use
Oct 01, 2013
A review of dozens of studies on the use of statin medications to prevent heart attacks shows that the commonly prescribed drugs pose no threat to short-term memory, and that they may even protect against dementia when taken ...
Roche 'extremely open' to talks with Novartis: report
Oct 01, 2013
The head of Swiss pharmaceutical giant Roche is open to renewed cooperation with competitor Novartis, he told the Financial Times in an interview published Tuesday.
User comments
© Medical Xpress 2011-2013, Phys.org network
(Medical Xpress)—At the request of two drug companies, the Food and Drug Administration (FDA) has announced that it will withdraw approvals for three of four arsenic-based drugs currently approved for use in food animal production. A fourth arsenic-based drug used to make turkeys and chickens grow faster, among other purposes, will remain on the market.
FDA's move follows a study led by the Johns Hopkins Center for a Livable Future (CLF) and published in May 2013 found clear evidence that using these drugs in chicken production increased levels of inorganic arsenic, a known carcinogen, in chicken breast meat.
Earlier this year, the Center for Food Safety (CFS) and the Institute for Agriculture and Trade Policy (IATP) sued the FDA after the agency did not respond to a 2009 petition asking it to withdraw the approvals of all four drugs. The lawsuit forced FDA to respond by today.
"Our research found clear evidence that using arsenic-based drugs in poultry production increased people's exposure to a potent carcinogen. The findings made it clear that continuing to use these drugs would increase the risk of cancer and possibly other diseases too," said Keeve Nachman, PhD, MHS, a member of the faculty of the Bloomberg School of Public Health and lead author of the CLF study. "We are glad that FDA and drug companies have bowed to public health concerns about using arsenic to produce chickens and turkeys, but the agency still has work to do. FDA must withdraw the approvals for nitarsone so that arsenic is no longer used to make food that people eat," added Nachman.
Specifically, the approvals for roxarsone, arsanilic acid, and carbarsone will be withdrawn by FDA at the request of the companies that hold the approvals. Nitarsone, the fourth arsenic-based drug and the only one that has been marketed since 2011, will remain approved and available for use.
The study, "Roxarsone, Inorganic Arsenic, and Other Arsenic Species in Chicken: A U.S.-Based Market Basket Sample," was published in the journal Environmental Health Perspectives in May 2013.
Explore further: Poultry drug increases levels of toxic arsenic in chicken meat
More information: www.jhsph.edu/news/news-releases/2013/nachman_arsenic_chicken.html
Medical Xpress on facebook
Related Stories
Poultry drug increases levels of toxic arsenic in chicken meat
May 13, 2013
(Medical Xpress)—Chickens likely raised with arsenic-based drugs result in chicken meat that has higher levels of inorganic arsenic, a known carcinogen, according to a new study led by researchers at theJohns Hopkins Center ...
Coordinated approach needed to protect from arsenic exposure
May 02, 2013
(HealthDay)—A coordinated approach is necessary for monitoring and regulating the arsenic content of foods, according to a viewpoint piece published online April 29 in JAMA Internal Medicine.
US: Rice is safe, despite small levels of arsenic
Sep 06, 2013
The U.S. Food and Drug Administration says consumers should not worry too much about levels of arsenic in rice—but should vary their diets just in case.
Pfizer will stop selling poultry-pumping drug: US
Jun 08, 2011
The pharmaceutical giant Pfizer will voluntarily suspend US sales of a poultry-pumping additive after studies showed it can leave traces of arsenic in chicken livers, the US government said on Wednesday.
Denmark warns against rice for children
May 15, 2013
Denmark's Veterinary and Food Administration said Wednesday that parents should stop giving their children rice cakes and rice milk, saying the products contained unacceptable levels of inorganic arsenic.
Recommended for you
Doctors still prescribe antibiotics too often, study finds (Update)
17 hours ago
Repeated warnings that antibiotics don't work for most sore throats and bronchitis have failed to stop overuse: U.S. doctors prescribed these drugs for most adults seeking treatment at a rate that remained high over more ...
Following bariatric surgery, use of opioids increases among chronic opioid users
Oct 01, 2013
In a group of patients who took chronic opioids for noncancer pain and who underwent bariatric surgery, there was greater chronic use of opioids after surgery compared with before, findings that suggest the need for proactive ...
Brintellix approved for major depressive disorder
Oct 01, 2013
(HealthDay)—Brintellix (vortioxetine) has been approved by the U.S. Food and Drug Administration to treat adults with major depressive disorder, often referred to as depression.
Over-the counter as effective as Rx at managing post-tonsillectomy pain
Oct 01, 2013
You may be able to eat all of the ice cream you want after having your tonsils removed, but researchers at Henry Ford Hospital in Detroit say you don't necessarily need a prescription to reduce post-operative pain—an over-the-counter ...
Statin medications may prevent dementia and memory loss with longer use
Oct 01, 2013
A review of dozens of studies on the use of statin medications to prevent heart attacks shows that the commonly prescribed drugs pose no threat to short-term memory, and that they may even protect against dementia when taken ...
Roche 'extremely open' to talks with Novartis: report
Oct 01, 2013
The head of Swiss pharmaceutical giant Roche is open to renewed cooperation with competitor Novartis, he told the Financial Times in an interview published Tuesday.
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment